Eradication: Ethics, Autonomy, Priorities Alan R. Hinman, MD, MPH Task Force for Global Health May 3, 2011.

Slides:



Advertisements
Similar presentations
Global Gender and Climate Aliance CLIMATE CHANGE ADAPTATION Reducing the vulnerability to extreme events through prevention.
Advertisements

February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Global Measles and Rubella Strategic Plan
Restructuring the Cancer Programs and Task Force Workgroups.
Note: Lists provided by the Conference Board of Canada
Breaking Silos: TB and Poverty Bobby Ramakant, Rachael Thomson STOP TB Partnership TB and Poverty Subgroup.
The Global Burden of Hepatitis C Dr Daniel Lavanchy World Health Organization (WHO) Geneva, Switzerland 3 rd Paris Hepatitis Conference.
The Millennium Development Goals the fight against global poverty and inequality.
Disease Eradication Prof. Ashry Gad Mohamed Consultant Epidemiologist.
A tisket, a tasket, is MNCH in your benefits basket? March 2, 2015.
Technical Advisory Group meeting, WHO/WPRO
Achieving Lasting Impacts Understanding the shift to more programmatic approaches in CARE.
Global Health Program Guiding Principles April 2002.
Advocacy as a tool for scaling up political and professional commitment in VISION 2020 Dr. Abdulaziz AlRajhi Executive Co-Chair, IAPB-EMR Dr. Mansur Rabiu.
Creating a service Idea. Creating a service Networking / consultation Identify the need Find funding Create a project plan Business Plan.
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
TITLE from VIEW and SLIDE MASTER | 27 July 2006 AID EFFECTIVENESS FOR HEALTH: TOWARDS THE 4TH HIGH-LEVEL FORUM, BUSAN AID EFFECTIVENESS FOR HEALTH.
Title written in CAPITAL letters, broken into 2 lines, if it fits with the length of the words Optional: Cover this area with photo. Proportions are approx.
Capacity Building for Better Agricultural Statistics Misha Belkindas and Graham Eele Development Data Group, World Bank.
The Millennium Development Goals and Performance Millennium Development Goals Website
Ethical and Legal Issues in Influenza Pandemic Alicia Ouellette Albany Law School.
Why are we here? The Rotary Foundation Seminar September 28, 2013.
Global Partnership on Disability and Development What is the GPDD? Presentation to JICA Group Training Course HIV/AIDS Section Judith Heumann, Lead Consultant,
T he Istanbul Principles and the International Framework Geneva, Switzerland June 2013.
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
Epilepsy and WHO | 17 Oct |1 | WHO's six-point agenda The overarching health needs 1.Promoting development 2.Fostering health security The strategic.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 2: BACKGROUND ON TUBERCULOSIS Insert country/ministry.
Defining a Program Approach Understanding the Program Approach and its potential for CIS June 2011.
Millennium Development Goals Carla AbouZahr Coordinator, Statistics, Monitoring and Analysis Department of Health Statistics and Informatics World Health.
Expected Learning Objectives Participants should understand the following: The concepts of ‘gender’ and ‘sex’. The term ‘gender equality.’ The importance.
WOMEN, CHILDREN, AND PUBLIC HEALTH MPH 600 INTRODUCTION TO PUBLIC HEALTH W. TWEEL, MD, MPH.
Concern Worldwide’s Approach to Disaster Risk Reduction.
WHO/OMS Improving and increasing investments in the health outcomes of the poor Macroeconomics and Health in context Dr. Sergio Spinaci, WHO Senegal, February.
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
Malaria Eradication: Ethics, Autonomy, Priorities David Brandling-Bennett Deputy Director, Malaria Infectious Diseases, Global Health Program May 3, 2011.
DRAFT PIP Framework Partnership Contribution: Factors to consider in selecting countries DRAFT PIP Framework Partnership Contribution: Factors to consider.
Conclusions 3 rd Meeting of National Influenza Centres in the Western Pacific and South East Asia Regions 18 – 20 August 2009 Beijing, China.
World Bank Social Development Strategy, June 2002 A Social Development Strategy for the World Bank Susan Jacobs Matzen Social Development Specialist World.
Making Lab network sustainable after Polio Presenter: Varavikova Elena, MD, PhD, MPH.
Objectives of Luxor malaria elimination course 2012 Describe the epidemiological bases for malaria control and elimination. Give an account on the historical.
Nutrition Program Planning Group of education and related activities designed to change public eating habits in ways that promote health and treat disease.
Achieving MDGs How can the SCN working group on Household Food Security contribute?
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
CARE Ethiopia Program Shift: Impact Groups The Great Run Begins: Defining our Program Impact Groups 1 st Meeting of the Impact Group Task Force (8 September.
Objectives of Lipa malaria elimination course 2014 Give an account on the historical background on malaria control and elimination, including current concepts.
HIV/AIDS A MAJOR DEVELOPMENT CONCERN FOR THE AFRICAN DEVELOPMENT BANK March 2008.
Sustainable Development Tools and the SD Initiative in the Arab Region (SDIAR) Presentation: Hend Zaki.
Hepatitis C treatment as prevention: Could it work?
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
Lesson 14Page 1 of 26 Surveillance Issues in Developing Countries Lesson 14.
The US Preventive Services Task Force: Potential Impact on Medicare Coverage Ned Calonge, MD, MPH Chair, USPSTF.
Implementation Science: Finding Common Ground and Perspectives Laura Reichenbach, Evidence Project, Population Council International Conference on Family.
1 Disaster epidemiology Professor Vilius Grabauskas Kaunas University of Medicine, Kaunas, Lithuania NATO supported advanced research workshop, Kaunas,
33 MEETING OF THE UNAIDS PROGRAMME COORDINATING BOARD GENEVA, SWITZERLAND DECEMBER 2013 THE EQUITY DEFICIT: UNEQUAL AND UNFAIR ACCESS TO HIV TREATMENT,
Effect of Clinical Program Integration on Eliminating Disparities in Access to Care P. Tambe, M. Allen, R. Lewis-Hardy, T. Dupree-Bright, E. Benning, S.
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) What is Health? What is Public Health? Global Health Training.
A proposed process for participatory decision on standards of care Daniel Tarantola, M.D., The University of New South Wales, Sydney, Australia IAS Conference,
Digital Health Solutions for Vulnerable Populations: Addressing the Needs of Vulnerable Populations through Digital Innovation June
Poverty and conservation
Musculoskeletal Health in Europe
ДЭМБ, Сүрьеэтэй тэмцэх стратеги он: Бүсийн хэтийн төлөвлөгөө
Stakeholder Consultation
Introduction to Public Health Nutrition
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Dr Timothy Armstrong Coordinator
Donor Perspective on Aid Effectiveness (a short recap of our commitments) Mary Cobb 2 February 2011.
Ministries of Health of the Americas pledge action to keep the region free of measles and rubella During the 29th Pan American Sanitary Conference, Ministers.
Presentation transcript:

Eradication: Ethics, Autonomy, Priorities Alan R. Hinman, MD, MPH Task Force for Global Health May 3, 2011

Eradication Permanent reduction to zero of the worldwide incidence of infection caused by a specific agent as a result of deliberate efforts; intervention measures are no longer needed (Dahlem, 1997)

Eradication Permanent reduction to zero of the worldwide incidence of infection caused by a specific agent as a result of deliberate efforts; intervention measures are no longer needed (Dahlem, 1997) The absence of disease in a defined geographical area as a result of deliberate control efforts (Ernst Strungmann, 2010)

Criteria for assessing eradicability of diseases and conditions – ITFDE, 1993 Scientific feasibility –epidemiologic vulnerability –effective, practical intervention available –demonstrated feasibility of elimination Political will/popular support –perceived burden of disease –expected cost of eradication –synergy of eradication efforts with other interventions –necessity for eradication rather than control

Ethical Dilemmas in Current Planning for Polio Eradication “We consider it shortsighted for donors to use their considerable influence to promote polio eradication if this delays or diverts long-term investment by poor countries in sustainable health systems….Polio eradication will be a gift to the 21 st century only if donors and governments act in partnership to ensure long-term benefits for the least developed countries and poorest communities.” Taylor, Cutts,Taylor. AJPH 1997;87:

Conference on Global Disease Elimination and Eradication as Public Health Strategies Goal - assess the role of eradication or elimination in decreasing global burden of disease and more effectively utilizing health resources Atlanta, February 23-25, 1998

Actual and potential dangers of eradication for the health system and health development Diversion of resources from existing support to basic services Opportunities “forgone,” especially for countries for which the eradication effort is of low impact in terms of health outcomes Potential decrease in resources available for research Failure to accurately estimate the needs of the eradication efforts Enthusiasm for eradication could lead to many simultaneous eradication efforts and induce failure

Sustainable health services development - 1 Eradication programs should have two kinds of objectives: –reduction of the target disease to zero incidence which can be maintained even when all intervention is ceased –strengthening and further development of health systems, especially functions such as monitoring and surveillance, supervision, and program management

Sustainable health services development - 2 Potential benefits should be identified and delineated at the start of any eradication initiative As must be done for the disease eradication objective, measurable targets for achieving development benefits should be set and the program should be held accountable for their realization

Sustainable health services development - 3 Successful eradication programs are powerful examples of effective management. As such, they build program management capacities to be carried to other health programs Eradication initiatives should strive to demonstrate the principles of effective surveillance…which can be readily adapted to meet the needs of other national priority programs after eradication is achieved

Sustainable health services development - 4 Resources for eradication activities should be additional to those available for basic health care services and should not be provided at the detriment of existing services or those that are planned, without careful and explicit consideration of the consequences “Eradication programs should not be held responsible for curing the ills of existing health systems”

Candidates for eradication ITFDE, 2008 Dracunculiasis (Guinea worm) Lymphatic filariasis Measles Mumps Poliomyelitis Rubella Taeniasis/cysticercosis (pork tapeworm)

Disease eradication Eradication is for everyone, everywhere and forever. Eradication is the ultimate in equity.